Published in N Engl J Med on July 10, 1975
Pathogenicity of Candida tropicalis and Candida albicans after gastrointestinal inoculation in mice. Infect Immun (1980) 1.34
How much does medical technology cost? Bull N Y Acad Med (1978) 1.17
Acute and late radiation injury in rhesus monkey parotid glands. Evidence of interphase cell death. Am J Pathol (1986) 1.16
Pathogenesis of acute radiation injury to the rectum. A prospective study in patients. Int J Colorectal Dis (1994) 0.90
TRAM flap breast reconstruction after radiation treatment. Ann Surg (1995) 0.85
New approaches to radiation protection. Front Oncol (2015) 0.85
In vivo rectal inflammatory mediator changes with radiotherapy to the pelvis. Gut (1993) 0.82
RNA Nanoparticles Derived from Three-Way Junction of Phi29 Motor pRNA Are Resistant to I-125 and Cs-131 Radiation. Nucleic Acid Ther (2015) 0.79
γ-Tocotrienol prevents 5-FU-induced reactive oxygen species production in human oral keratinocytes through the stabilization of 5-FU-induced activation of Nrf2. Int J Oncol (2015) 0.77
Endoscopic gastrointestinal laser therapy. West J Med (1985) 0.75
Oligometastases. J Clin Oncol (1995) 4.95
A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. J Clin Oncol (1989) 2.71
Radiation therapy of early carcinoma of the breast without mastectomy. Cancer (1980) 2.49
Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast. Int J Radiat Oncol Biol Phys (1979) 2.10
Patterns of presentation of Hodgkin disease. Implications for etiology and pathogenesis. Cancer (1993) 2.07
Stopping metastases at their source. N Engl J Med (1997) 2.03
Intra-articular radiation synovectomy. Clin Orthop Relat Res (1984) 2.01
Pathologic predictors of early local recurrence in Stage I and II breast cancer treated by primary radiation therapy. Cancer (1984) 1.95
Hodgkin's disease: evidence for a tumor-associated antigen. N Engl J Med (1971) 1.83
Clinical progression of breast cancer malignant behavior: what to expect and when to expect it. J Clin Oncol (2000) 1.78
Pathogenesis of Hodgkin's disease. Lancet (1972) 1.77
Proliferative capacity of murine hematopoietic stem cells. Proc Natl Acad Sci U S A (1978) 1.62
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Spatial and temporal control of gene therapy using ionizing radiation. Nat Med (1995) 1.59
Natural history of node-negative breast cancer: a study of 826 patients with long-term follow-up. J Clin Oncol (1995) 1.59
Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years. J Clin Oncol (1989) 1.57
Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin. Cancer Res (2000) 1.55
Prostate-specific antigen levels in African-Americans correlate with insurance status as an indicator of socioeconomic status. Cancer J Sci Am (2006) 1.54
Considerations in the radiation therapy of Wilms' tumor. Cancer (1973) 1.51
Race and the Will Rogers phenomenon in prostate cancer. Cancer J Sci Am (1998) 1.50
Breast cancer metastatic phenotype as predicted by histologic tumor markers. Cancer J Sci Am (1997) 1.48
Limited surgery and radiotherapy for early breast cancer. N Engl J Med (1985) 1.48
Loss of hematopoietic stem cell self-renewal after bone marrow transplantation. Blood (1989) 1.45
It's too soon to know. J Natl Cancer Inst (1990) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Effects of noise and noise suppression on speech perception by cochlear implant users. Ear Hear (1992) 1.40
Advances in radiation oncology. Lancet (1997) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
The key and the lamppost. J Clin Oncol (1999) 1.39
The benefits of mammography are not limited to women of ages older than 50 years. Cancer (1998) 1.39
A piece of my mind. Tales of the unnatural: return from the dean(d) JAMA (1998) 1.38
Evidence for structured variation in self-renewal capacity within long-term bone marrow cultures. Proc Natl Acad Sci U S A (1980) 1.38
The first century of cancer chemotherapy. J Clin Oncol (1998) 1.35
Interstitial hypertension in carcinoma of uterine cervix in patients: possible correlation with tumor oxygenation and radiation response. Cancer Res (1991) 1.35
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Contralateral breast carcinoma: an assessment of risk and prognosis in stage I (T1N0M0) and stage II (T1N1M0) patients with 20-year follow-up. Surgery (1989) 1.34
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Radiation therapy as initial treatment for early stage cancer of the breast without mastectomy. Cancer (1977) 1.29
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Nature of the hemopoietic stem cell compartment and its proliferative potential. Blood Cells (1979) 1.26
Race and clinical outcome in breast cancer in a series with long-term follow-up evaluation. J Clin Oncol (1997) 1.24
Recipient preparation for bone marrow transplantation. I. Efficacy of total-body irradiation and busulfan. Transplantation (1988) 1.21
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Effect of radiation on interstitial fluid pressure and oxygenation in a human tumor xenograft. Cancer Res (1996) 1.19
Physics of gamma knife approach on convergent beams in stereotactic radiosurgery. Int J Radiat Oncol Biol Phys (1990) 1.19
Studies of antigens associated with Hodgkin's disease. Blood (1972) 1.18
Treatment of carcinoma of the breast by radiation therapy. Cancer (1977) 1.15
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin. Cancer Res (1998) 1.13
The role of lymphatic obstruction in the formation of ascites in a murine ovarian carcinoma. Cancer Res (1972) 1.12
Sequelae of breast irradiation. JAMA (1985) 1.12
Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer. J Natl Cancer Inst (1996) 1.11
Results of treating stage III carcinoma of the breast by primary radiation therapy. Cancer (1979) 1.09
Permanent loss in stem cell self renewal capacity following stress to the marrow. Blood (1988) 1.07
Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07
The significance of mediastinal involvement in early stage Hodgkin's disease. Cancer (1978) 1.05
Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05
A variant estrogen receptor messenger ribonucleic acid is associated with reduced levels of estrogen binding in human mammary tumors. Mol Endocrinol (1988) 1.04
Stem cell depletion: an explanation of the late effects of cytotoxins. Int J Radiat Oncol Biol Phys (1977) 1.04
Proliferation kinetics of a human breast cancer line in vitro following treatment with 17beta-estradiol and 1-beta-D-arabinofuranosylcytosine. Cancer Res (1978) 1.02
Clinical-pathologic study of early breast cancer treated by primary radiation therapy. J Clin Oncol (1983) 1.01
Primary radiation therapy for early breast cancer: the experience at The Joint Center for Radiation Therapy. Int J Radiat Oncol Biol Phys (1981) 1.01
Breast relapse following primary radiation therapy for early breast cancer. I. Classification, frequency and salvage. Int J Radiat Oncol Biol Phys (1985) 1.01
Time course and prognosis of local recurrence following primary radiation therapy for early breast cancer. J Clin Oncol (1984) 1.01
Cellular X-ray repair parameters of early passage squamous cell carcinoma lines derived from patients with known responses to radiotherapy. Br J Cancer (1984) 1.00
Haematopoietic stem cells: evidence for competing proliferative demands. Nature (1967) 1.00
Search for supersymmetry in events with three leptons and missing transverse momentum in √[s]=7 TeV pp collisions with the ATLAS detector. Phys Rev Lett (2012) 0.99
Anti-B1 monoclonal antibody and complement treatment in autologous bone-marrow transplantation for relapsed B-cell non-Hodgkin's lymphoma. Lancet (1984) 0.98
Tumor necrosis factor alpha (TNF-alpha) gene therapy targeted by ionizing radiation selectively damages tumor vasculature. Cancer Res (1996) 0.98
Decline in bone marrow proliferative capacity as a function of age. Blood (1982) 0.98
Differential effects of cytotoxic agents on hematopoietic progenitors. Cancer Res (1981) 0.97
Improvement in quality of survival following whole-brain irradiation for brain metastasis. Radiology (1968) 0.96
5-125I-iododeoxyuridine as prototype for radionuclide therapy with Auger emitters. Nature (1977) 0.96
Management of spinal cord compression. Semin Oncol (1978) 0.96
Astatine-211--tellurium radiocolloid cures experimental malignant ascites. Science (1981) 0.95
Individual characterisation of the metastatic capacity of human breast carcinoma. Eur J Cancer (2000) 0.93
Aging, progression, and phenotype in breast cancer. J Clin Oncol (1998) 0.93
Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents. Exp Hematol (1993) 0.93
The effect of compression ratio and release time on the categorical rating of sound quality. J Acoust Soc Am (1998) 0.93
Effective atomic numbers of composite materials for total and partial interaction processes for photons, electrons, and protons. Med Phys (1997) 0.91
Observations on survival curve analysis with particular reference to breast cancer treatment. Cancer (1986) 0.91
Preferred listening levels for linear and slow-acting compression hearing aids. Ear Hear (1995) 0.91
Improved survival following combined radiation therapy and chemotherapy for unfavorable prognosis stage I-II non-Hodgkin's lymphomas. J Clin Oncol (1985) 0.91
The use of pathologic features in selecting the extent of surgical resection necessary for breast cancer patients treated by primary radiation therapy. Ann Surg (1985) 0.91
Cosmetic results following primary radiation therapy for early breast cancer. Cancer (1984) 0.90
Tolerance of the intestine to radiation therapy. Surg Gynecol Obstet (1980) 0.90
211At radiocolloid therapy: further observations and comparison with radiocolloids of 32P, 165Dy, and 90Y. Int J Radiat Oncol Biol Phys (1984) 0.90
Total body irradiation as treatment for lymphosarcoma. Int J Radiat Oncol Biol Phys (1976) 0.90
The 5-year results of a randomized trial of adjuvant radiation therapy after chemotherapy in breast cancer patients treated with mastectomy. J Clin Oncol (1987) 0.89
Limited proliferation of stem cells surviving alkylating agents. Nature (1976) 0.89
Distribution of fast- and slow-migrating Hodgkin's tumor-associated antigens. Cancer Res (1974) 0.89
Multisystem stem cell failure after apparent recovery from alkylating agents. Cancer Res (1978) 0.89
Reversal of donor myocardial dysfunction by triiodothyronine replacement therapy. J Heart Lung Transplant (1994) 0.89
Current studies in Hodgkin's disease: what laparotomy has wrought. N Engl J Med (1974) 0.89
Translational strategies exploiting TNF-alpha that sensitize tumors to radiation therapy. Cancer Gene Ther (2008) 0.89
Cancer of the esophagus: a brighter future? J Clin Oncol (1984) 0.88
A long lasting proliferative defect in the hematopoietic stem cell compartment following cytotoxic agents. Int J Radiat Oncol Biol Phys (1979) 0.88
Natural history of node-positive breast cancer: the curability of small cancers with a limited number of positive nodes. J Clin Oncol (1996) 0.88
Influence of mediastinal adenopathy on site and frequency of relapse in patients with Hodgkin's disease. Cancer Treat Rep (1982) 0.88